3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, Non-Hodgkin
3
Lymphoma, B-Cell
2
Lymphoma
2
Triple Negative Breast Neoplasms
1
Neuroblastoma
1
Multiple Myeloma
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Hematologic Diseases
1
Ganglioneuroblastoma
1
Burkitt Lymphoma
1
Interventions
Specimen Handling
6
Magnetic Resonance Spectroscopy
6
Biopsy
6
Doxorubicin
5
X-Rays
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Cyclophosphamide
4
pembrolizumab
3
liposomal doxorubicin
3
fludarabine
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
fludarabine phosphate
2
ensartinib
2
atezolizumab
2
anlotinib
2
Temozolomide
2
Radiation
2
Irinotecan
2
Ifosfamide
2
Carboplatin
2
Bevacizumab
2
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Leukapheresis
×
30 days
×
Clear all
No trials found.